With the identification of specific patient populations in which targetted antineoplastics show a clear benefit, the high price of these therapies will continue to be supported

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 493, 2005-12-17 , pp. 19-19(1)

Publisher: Adis International

Keywords: Antineoplastics, therapeutic use; Cancer, treatment; Cost-allocation; Pharmaceutical-industry

Document Type: Short communication

Publication date: 2005-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers